NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...

On Friday, Jefferies analyst Glen Santangelo adjusted the price target for Viatris (NASDAQ:VTRS) stock, bringing it down to $13.00 from the previous $15.00 while maintaining a Buy rating on the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...

The consensus price target of $11 implies 16.03% upside. Viatris Inc. (NASDAQ:VTRS) stock is down 23.86% year-to-date. Overall VRT ranks 12th on our list of the large-cap stocks that are plunging ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VIATRIS INC. (VTRS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

NEW YORK, March 13, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS ...

The Law Offices of Frank R. Cruz announces an investigation of Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of investors concerning the Company's possible violations of federal ...

BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ ...